MedWellAI（MWAI）株式概要Integrated Ventures, Inc.はデジタル通貨のマイニングに従事している。 詳細MWAI ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析マイナスの株主資本 キャッシュランウェイが1年未満である 意味のある時価総額がありません ( $2M )US市場と比較して、過去 3 か月間の株価の変動が非常に大きい+1 さらなるリスクすべてのリスクチェックを見るMWAI Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.26331.1% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-32m7m2016201920222025202620282031Revenue US$304.5kEarnings US$35.7kAdvancedSet Fair ValueView all narrativesMedWellAI Inc. 競合他社Windfall GeotekSymbol: OTCPK:WINK.FMarket cap: US$2.6mVocodia HoldingsSymbol: OTCPK:VHAIMarket cap: US$1.5mTancheng GroupSymbol: OTCPK:QSJCMarket cap: US$723.4kStagewise StrategiesSymbol: OTCPK:STWIMarket cap: US$1.9m価格と性能株価の高値、安値、推移の概要MedWellAI過去の株価現在の株価US$0.2652週高値US$0.8052週安値US$0.20ベータ2.511ヶ月の変化-28.91%3ヶ月変化-39.25%1年変化-22.87%3年間の変化-90.51%5年間の変化-98.91%IPOからの変化-99.90%最新ニュースお知らせ • May 08MedWellAI Inc. Reconfirms Yearly Revenue GuidanceMedWellAI Inc. reconfirmed yearly revenue guidance of $2.3 million.お知らせ • Feb 19MedWellAI Inc. announced delayed 10-Q filingOn 02/18/2026, MedWellAI Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Feb 11MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC.MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC on February 10, 2026. In a related transaction MedWellAI signed a letter of intent to acquire Ageless Cosmetic Surgery Centers, Inc. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is within 60 days.お知らせ • Oct 02MedWellAI Inc. Auditor Raises 'Going Concern' DoubtMedWellAI Inc. filed its Annual on Sep 30, 2025 for the period ending Jun 30, 2025. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.お知らせ • Oct 01MedWellAI Inc. announced delayed annual 10-K filingOn 09/30/2025, MedWellAI Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 19MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD to Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused on $24.46 Billion Corporate Wellness MarketMedWellAi Inc. confirm the collaboration and execution of Software Development Agreement with BrighterMD, to develop and launch Company's latest initiative: TeleMD.Ai - Nationwide B2B and B2C Healthcare and Wellness Telemedicine Platform, with main focus on corporate healthcare benefits market. Scheduled to go live in October, 2025, TeleMD is designed to deliver a comprehensive telehealth primary care that is affordable and accessible for everyone. Clients will be able to access all the healthcare care they need through TeleMd's platform and technology, easy-to-use desktop and mobile apps, resulting in getting timely healthcare advice, eliminating travel and wait time to schedule appointments. This platform will offer (1) affordable monthly subscription plans (retail + corporate clients) with unlimited access to the healthcare providers and certified telehealth therapists, (2) nationwide 365/24/7 access via smart device or desktop, (3) no co-pays, no cancelation or any other additional fees/charges. With innovative stack that includes Cloudflare, Google Font API, and Bootstrap, TeleMD is committed to leveraging technology for delivering healthcare services. BrighterMD solutions and their technology approach, provide an opportunity for TeleMD to offer their tech-savvy corporate clients with effective options on how to integrate the latest healthcare solutions into their current systems. TeleMD Ai is focused on two markets segments: Business-To-Public And Business-To-Business. Users will have access to unlimited appointments, 24 hours a day from the comfort of their home or office. B2B - Discounted Group Pricing for Companies: TeleMD delivers affordable healthcare for employees, while reducing premiums with high quality comprehensive telemedicine solution. Now, employers can offer extra benefits with primary care online, provide employees and their families with unlimited private appointments that will't be shared with insurers or employers. All employees can quickly and conveniently access team of medical professionals, as frequently as they need. TeleMD is a simple and effective addition to any benefits package. Enrolling employees into the program is available via API integration, or via EDI file transfer. Simple to set up, easy to use. Company's goal is to provide a seamless, robust and affordable healthcare solution for employers to offer their employees. By choosing TeleMD's telehealth services, employers will reduce insurance premiums, while offering convenient and extensive primary care and mental health support to employees that they can use whenever they need it. Additional services include: (1) Financial and Legal Consultations, (2) Life Coaching, (3) Medical Advocacy and (4) Nutritional Counseling. TeleMd's AI-enhanced platform will offer new ways to provide mental support and care. It will feature Ai Agent that can identify signs of depression or distress and provide on-the-go support, and connect individuals with human therapies when needed. 90% of chronic condition meds home delivered at a $0 copay. 125 acute meds at any pharmacy at a $0copay. TeleMD offers diabetes program at no added cost and OTC meds at a discount. Members save up to 80% on prescriptions; at most major RX retailers as well as 80% on any lab work at any Quest Diagnostics location. Bilingual Services: TeleMD differentiates itself by offering bilingual (English+ Spanish) Board-Certified doctors and mental health therapists. This FREE feature could be a valuable selling point for many corporations with diverse workforces that seek healthcare solutions that cater to employees with varying language needs, presenting a market niche to target. Currently FDA Registered with clinical trials completed. This platform l allows clients to take complete control of everyday health and wellness. Doctegrity is focused on providing (1) affordable telemedicine: cost-effective way for employers to provide healthcare benefits to their employees, including those who may not have traditional insurance coverage, (2) comprehensive solutions and care: their services include 365/24/7 access to board-certified physicians and licensed therapists for both physical and mental health needs and mental health therapists.最新情報をもっと見るRecent updatesお知らせ • May 08MedWellAI Inc. Reconfirms Yearly Revenue GuidanceMedWellAI Inc. reconfirmed yearly revenue guidance of $2.3 million.お知らせ • Feb 19MedWellAI Inc. announced delayed 10-Q filingOn 02/18/2026, MedWellAI Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Feb 11MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC.MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC on February 10, 2026. In a related transaction MedWellAI signed a letter of intent to acquire Ageless Cosmetic Surgery Centers, Inc. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is within 60 days.お知らせ • Oct 02MedWellAI Inc. Auditor Raises 'Going Concern' DoubtMedWellAI Inc. filed its Annual on Sep 30, 2025 for the period ending Jun 30, 2025. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.お知らせ • Oct 01MedWellAI Inc. announced delayed annual 10-K filingOn 09/30/2025, MedWellAI Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 19MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD to Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused on $24.46 Billion Corporate Wellness MarketMedWellAi Inc. confirm the collaboration and execution of Software Development Agreement with BrighterMD, to develop and launch Company's latest initiative: TeleMD.Ai - Nationwide B2B and B2C Healthcare and Wellness Telemedicine Platform, with main focus on corporate healthcare benefits market. Scheduled to go live in October, 2025, TeleMD is designed to deliver a comprehensive telehealth primary care that is affordable and accessible for everyone. Clients will be able to access all the healthcare care they need through TeleMd's platform and technology, easy-to-use desktop and mobile apps, resulting in getting timely healthcare advice, eliminating travel and wait time to schedule appointments. This platform will offer (1) affordable monthly subscription plans (retail + corporate clients) with unlimited access to the healthcare providers and certified telehealth therapists, (2) nationwide 365/24/7 access via smart device or desktop, (3) no co-pays, no cancelation or any other additional fees/charges. With innovative stack that includes Cloudflare, Google Font API, and Bootstrap, TeleMD is committed to leveraging technology for delivering healthcare services. BrighterMD solutions and their technology approach, provide an opportunity for TeleMD to offer their tech-savvy corporate clients with effective options on how to integrate the latest healthcare solutions into their current systems. TeleMD Ai is focused on two markets segments: Business-To-Public And Business-To-Business. Users will have access to unlimited appointments, 24 hours a day from the comfort of their home or office. B2B - Discounted Group Pricing for Companies: TeleMD delivers affordable healthcare for employees, while reducing premiums with high quality comprehensive telemedicine solution. Now, employers can offer extra benefits with primary care online, provide employees and their families with unlimited private appointments that will't be shared with insurers or employers. All employees can quickly and conveniently access team of medical professionals, as frequently as they need. TeleMD is a simple and effective addition to any benefits package. Enrolling employees into the program is available via API integration, or via EDI file transfer. Simple to set up, easy to use. Company's goal is to provide a seamless, robust and affordable healthcare solution for employers to offer their employees. By choosing TeleMD's telehealth services, employers will reduce insurance premiums, while offering convenient and extensive primary care and mental health support to employees that they can use whenever they need it. Additional services include: (1) Financial and Legal Consultations, (2) Life Coaching, (3) Medical Advocacy and (4) Nutritional Counseling. TeleMd's AI-enhanced platform will offer new ways to provide mental support and care. It will feature Ai Agent that can identify signs of depression or distress and provide on-the-go support, and connect individuals with human therapies when needed. 90% of chronic condition meds home delivered at a $0 copay. 125 acute meds at any pharmacy at a $0copay. TeleMD offers diabetes program at no added cost and OTC meds at a discount. Members save up to 80% on prescriptions; at most major RX retailers as well as 80% on any lab work at any Quest Diagnostics location. Bilingual Services: TeleMD differentiates itself by offering bilingual (English+ Spanish) Board-Certified doctors and mental health therapists. This FREE feature could be a valuable selling point for many corporations with diverse workforces that seek healthcare solutions that cater to employees with varying language needs, presenting a market niche to target. Currently FDA Registered with clinical trials completed. This platform l allows clients to take complete control of everyday health and wellness. Doctegrity is focused on providing (1) affordable telemedicine: cost-effective way for employers to provide healthcare benefits to their employees, including those who may not have traditional insurance coverage, (2) comprehensive solutions and care: their services include 365/24/7 access to board-certified physicians and licensed therapists for both physical and mental health needs and mental health therapists.お知らせ • May 16Integrated Ventures, Inc. announced delayed 10-Q filingOn 05/15/2025, Integrated Ventures, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 16Integrated Ventures, Inc. announced delayed 10-Q filingOn 11/15/2024, Integrated Ventures, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Sep 30Integrated Ventures, Inc. Auditor Raises 'Going Concern' DoubtIntegrated Ventures, Inc. filed its 10-K on Sep 28, 2022 for the period ending Jun 30, 2022. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.お知らせ • May 15Integrated Ventures, Inc. Provides Revenue Guidance for the Full Year 2021Integrated Ventures, Inc. provided revenue guidance for the full year 2021. For the year, total revenues for 2021 are projected to be in $2.3 million to $2.4 million range with a 60%+ gross margin.お知らせ • Jan 24Integrated Ventures, Inc. announced that it expects to receive $3 million in funding from BHP Capital NY, Inc.Integrated Ventures, Inc. (OTCPK:INTV) announced that it has executed a binding term sheet for a private placement of convertible preferred series C stock led by returning investor BHP Capital NY, Inc. for gross proceeds of $3 million on January 22, 2021. The transaction will be completed in tranches and the company expects to receive an initial tranche in next few days. The investor has received a right to convert newly registered preferred stock into common shares at a fixed conversion price of $0.068.お知らせ • Sep 22Integrated Ventures, Inc. announced that it expects to receive $1 million in funding from Eagle Equities, LLCIntegrated Ventures, Inc. (OTCPK:INTV)announced that it has entered into a securities purchase agreement with Eagle Equities, LLC for private placement of a 6% convertible redeemable note due February 4, 2022 for gross proceeds of $1,000,000 on August 4, 2020. The note will carry a fixed interest coupon of 6% per annum, issued at a discount of 8% and will mature on February 4, 2022. The note provides the holder the right to convert the note into shares of the company’s common stock at a price for each share of common stock equal to the lower of 70% of market price as reported on the National Quotations Bureau OTC Market exchange which the company’s shares are traded or any exchange upon which the common stock may be traded in the future, for the fifteen prior trading days including the day upon which a notice of Conversion is received by the company. The company will receive funding in tranches, $250,000 in its first and second tranche. The company shall not consummate the sale of any convertible securities until the earlier of 30 days after purchase of the second tranche or, if the second tranche is not funded, then 60 days after the closing date of the first tranche. The company will pay $6,000 as legal fees in its first and second tranche. The company issued the note pursuant to exemption provided under Regulation D. On the same day, the company has received its first tranche of $250,000.株主還元MWAIUS SoftwareUS 市場7D1.2%-2.0%1.4%1Y-22.9%-17.7%25.7%株主還元を見る業界別リターン: MWAI過去 1 年間で-17.7 % の収益を上げたUS Software業界を下回りました。リターン対市場: MWAIは、過去 1 年間で25.7 % のリターンを上げたUS市場を下回りました。価格変動Is MWAI's price volatile compared to industry and market?MWAI volatilityMWAI Average Weekly Movement30.3%Software Industry Average Movement10.0%Market Average Movement7.2%10% most volatile stocks in US Market16.8%10% least volatile stocks in US Market3.1%安定した株価: MWAIの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: MWAIの weekly volatility ( 30% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/a1Steve Rubakhwww.medwellai.comIntegrated Ventures, Inc.はデジタル通貨の採掘に従事している。マイニング機器やマイニングリグを製造・販売している。本拠地はペンシルベニア州タイオガ。もっと見るMedWellAI Inc. 基礎のまとめMedWellAI の収益と売上を時価総額と比較するとどうか。MWAI 基礎統計学時価総額US$1.72m収益（TTM）-US$2.20m売上高(TTM)US$1.86m0.9xP/Sレシオ-0.8xPER（株価収益率MWAI は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計MWAI 損益計算書（TTM）収益US$1.86m売上原価US$1.28m売上総利益US$582.41kその他の費用US$2.78m収益-US$2.20m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-0.34グロス・マージン31.25%純利益率-118.04%有利子負債／自己資本比率-6.6%MWAI の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/21 06:15終値2026/06/18 00:00収益2026/03/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MedWellAI Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 08MedWellAI Inc. Reconfirms Yearly Revenue GuidanceMedWellAI Inc. reconfirmed yearly revenue guidance of $2.3 million.
お知らせ • Feb 19MedWellAI Inc. announced delayed 10-Q filingOn 02/18/2026, MedWellAI Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Feb 11MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC.MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC on February 10, 2026. In a related transaction MedWellAI signed a letter of intent to acquire Ageless Cosmetic Surgery Centers, Inc. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is within 60 days.
お知らせ • Oct 02MedWellAI Inc. Auditor Raises 'Going Concern' DoubtMedWellAI Inc. filed its Annual on Sep 30, 2025 for the period ending Jun 30, 2025. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
お知らせ • Oct 01MedWellAI Inc. announced delayed annual 10-K filingOn 09/30/2025, MedWellAI Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 19MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD to Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused on $24.46 Billion Corporate Wellness MarketMedWellAi Inc. confirm the collaboration and execution of Software Development Agreement with BrighterMD, to develop and launch Company's latest initiative: TeleMD.Ai - Nationwide B2B and B2C Healthcare and Wellness Telemedicine Platform, with main focus on corporate healthcare benefits market. Scheduled to go live in October, 2025, TeleMD is designed to deliver a comprehensive telehealth primary care that is affordable and accessible for everyone. Clients will be able to access all the healthcare care they need through TeleMd's platform and technology, easy-to-use desktop and mobile apps, resulting in getting timely healthcare advice, eliminating travel and wait time to schedule appointments. This platform will offer (1) affordable monthly subscription plans (retail + corporate clients) with unlimited access to the healthcare providers and certified telehealth therapists, (2) nationwide 365/24/7 access via smart device or desktop, (3) no co-pays, no cancelation or any other additional fees/charges. With innovative stack that includes Cloudflare, Google Font API, and Bootstrap, TeleMD is committed to leveraging technology for delivering healthcare services. BrighterMD solutions and their technology approach, provide an opportunity for TeleMD to offer their tech-savvy corporate clients with effective options on how to integrate the latest healthcare solutions into their current systems. TeleMD Ai is focused on two markets segments: Business-To-Public And Business-To-Business. Users will have access to unlimited appointments, 24 hours a day from the comfort of their home or office. B2B - Discounted Group Pricing for Companies: TeleMD delivers affordable healthcare for employees, while reducing premiums with high quality comprehensive telemedicine solution. Now, employers can offer extra benefits with primary care online, provide employees and their families with unlimited private appointments that will't be shared with insurers or employers. All employees can quickly and conveniently access team of medical professionals, as frequently as they need. TeleMD is a simple and effective addition to any benefits package. Enrolling employees into the program is available via API integration, or via EDI file transfer. Simple to set up, easy to use. Company's goal is to provide a seamless, robust and affordable healthcare solution for employers to offer their employees. By choosing TeleMD's telehealth services, employers will reduce insurance premiums, while offering convenient and extensive primary care and mental health support to employees that they can use whenever they need it. Additional services include: (1) Financial and Legal Consultations, (2) Life Coaching, (3) Medical Advocacy and (4) Nutritional Counseling. TeleMd's AI-enhanced platform will offer new ways to provide mental support and care. It will feature Ai Agent that can identify signs of depression or distress and provide on-the-go support, and connect individuals with human therapies when needed. 90% of chronic condition meds home delivered at a $0 copay. 125 acute meds at any pharmacy at a $0copay. TeleMD offers diabetes program at no added cost and OTC meds at a discount. Members save up to 80% on prescriptions; at most major RX retailers as well as 80% on any lab work at any Quest Diagnostics location. Bilingual Services: TeleMD differentiates itself by offering bilingual (English+ Spanish) Board-Certified doctors and mental health therapists. This FREE feature could be a valuable selling point for many corporations with diverse workforces that seek healthcare solutions that cater to employees with varying language needs, presenting a market niche to target. Currently FDA Registered with clinical trials completed. This platform l allows clients to take complete control of everyday health and wellness. Doctegrity is focused on providing (1) affordable telemedicine: cost-effective way for employers to provide healthcare benefits to their employees, including those who may not have traditional insurance coverage, (2) comprehensive solutions and care: their services include 365/24/7 access to board-certified physicians and licensed therapists for both physical and mental health needs and mental health therapists.
お知らせ • May 08MedWellAI Inc. Reconfirms Yearly Revenue GuidanceMedWellAI Inc. reconfirmed yearly revenue guidance of $2.3 million.
お知らせ • Feb 19MedWellAI Inc. announced delayed 10-Q filingOn 02/18/2026, MedWellAI Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Feb 11MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC.MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC on February 10, 2026. In a related transaction MedWellAI signed a letter of intent to acquire Ageless Cosmetic Surgery Centers, Inc. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is within 60 days.
お知らせ • Oct 02MedWellAI Inc. Auditor Raises 'Going Concern' DoubtMedWellAI Inc. filed its Annual on Sep 30, 2025 for the period ending Jun 30, 2025. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
お知らせ • Oct 01MedWellAI Inc. announced delayed annual 10-K filingOn 09/30/2025, MedWellAI Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 19MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD to Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused on $24.46 Billion Corporate Wellness MarketMedWellAi Inc. confirm the collaboration and execution of Software Development Agreement with BrighterMD, to develop and launch Company's latest initiative: TeleMD.Ai - Nationwide B2B and B2C Healthcare and Wellness Telemedicine Platform, with main focus on corporate healthcare benefits market. Scheduled to go live in October, 2025, TeleMD is designed to deliver a comprehensive telehealth primary care that is affordable and accessible for everyone. Clients will be able to access all the healthcare care they need through TeleMd's platform and technology, easy-to-use desktop and mobile apps, resulting in getting timely healthcare advice, eliminating travel and wait time to schedule appointments. This platform will offer (1) affordable monthly subscription plans (retail + corporate clients) with unlimited access to the healthcare providers and certified telehealth therapists, (2) nationwide 365/24/7 access via smart device or desktop, (3) no co-pays, no cancelation or any other additional fees/charges. With innovative stack that includes Cloudflare, Google Font API, and Bootstrap, TeleMD is committed to leveraging technology for delivering healthcare services. BrighterMD solutions and their technology approach, provide an opportunity for TeleMD to offer their tech-savvy corporate clients with effective options on how to integrate the latest healthcare solutions into their current systems. TeleMD Ai is focused on two markets segments: Business-To-Public And Business-To-Business. Users will have access to unlimited appointments, 24 hours a day from the comfort of their home or office. B2B - Discounted Group Pricing for Companies: TeleMD delivers affordable healthcare for employees, while reducing premiums with high quality comprehensive telemedicine solution. Now, employers can offer extra benefits with primary care online, provide employees and their families with unlimited private appointments that will't be shared with insurers or employers. All employees can quickly and conveniently access team of medical professionals, as frequently as they need. TeleMD is a simple and effective addition to any benefits package. Enrolling employees into the program is available via API integration, or via EDI file transfer. Simple to set up, easy to use. Company's goal is to provide a seamless, robust and affordable healthcare solution for employers to offer their employees. By choosing TeleMD's telehealth services, employers will reduce insurance premiums, while offering convenient and extensive primary care and mental health support to employees that they can use whenever they need it. Additional services include: (1) Financial and Legal Consultations, (2) Life Coaching, (3) Medical Advocacy and (4) Nutritional Counseling. TeleMd's AI-enhanced platform will offer new ways to provide mental support and care. It will feature Ai Agent that can identify signs of depression or distress and provide on-the-go support, and connect individuals with human therapies when needed. 90% of chronic condition meds home delivered at a $0 copay. 125 acute meds at any pharmacy at a $0copay. TeleMD offers diabetes program at no added cost and OTC meds at a discount. Members save up to 80% on prescriptions; at most major RX retailers as well as 80% on any lab work at any Quest Diagnostics location. Bilingual Services: TeleMD differentiates itself by offering bilingual (English+ Spanish) Board-Certified doctors and mental health therapists. This FREE feature could be a valuable selling point for many corporations with diverse workforces that seek healthcare solutions that cater to employees with varying language needs, presenting a market niche to target. Currently FDA Registered with clinical trials completed. This platform l allows clients to take complete control of everyday health and wellness. Doctegrity is focused on providing (1) affordable telemedicine: cost-effective way for employers to provide healthcare benefits to their employees, including those who may not have traditional insurance coverage, (2) comprehensive solutions and care: their services include 365/24/7 access to board-certified physicians and licensed therapists for both physical and mental health needs and mental health therapists.
お知らせ • May 16Integrated Ventures, Inc. announced delayed 10-Q filingOn 05/15/2025, Integrated Ventures, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 16Integrated Ventures, Inc. announced delayed 10-Q filingOn 11/15/2024, Integrated Ventures, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Sep 30Integrated Ventures, Inc. Auditor Raises 'Going Concern' DoubtIntegrated Ventures, Inc. filed its 10-K on Sep 28, 2022 for the period ending Jun 30, 2022. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
お知らせ • May 15Integrated Ventures, Inc. Provides Revenue Guidance for the Full Year 2021Integrated Ventures, Inc. provided revenue guidance for the full year 2021. For the year, total revenues for 2021 are projected to be in $2.3 million to $2.4 million range with a 60%+ gross margin.
お知らせ • Jan 24Integrated Ventures, Inc. announced that it expects to receive $3 million in funding from BHP Capital NY, Inc.Integrated Ventures, Inc. (OTCPK:INTV) announced that it has executed a binding term sheet for a private placement of convertible preferred series C stock led by returning investor BHP Capital NY, Inc. for gross proceeds of $3 million on January 22, 2021. The transaction will be completed in tranches and the company expects to receive an initial tranche in next few days. The investor has received a right to convert newly registered preferred stock into common shares at a fixed conversion price of $0.068.
お知らせ • Sep 22Integrated Ventures, Inc. announced that it expects to receive $1 million in funding from Eagle Equities, LLCIntegrated Ventures, Inc. (OTCPK:INTV)announced that it has entered into a securities purchase agreement with Eagle Equities, LLC for private placement of a 6% convertible redeemable note due February 4, 2022 for gross proceeds of $1,000,000 on August 4, 2020. The note will carry a fixed interest coupon of 6% per annum, issued at a discount of 8% and will mature on February 4, 2022. The note provides the holder the right to convert the note into shares of the company’s common stock at a price for each share of common stock equal to the lower of 70% of market price as reported on the National Quotations Bureau OTC Market exchange which the company’s shares are traded or any exchange upon which the common stock may be traded in the future, for the fifteen prior trading days including the day upon which a notice of Conversion is received by the company. The company will receive funding in tranches, $250,000 in its first and second tranche. The company shall not consummate the sale of any convertible securities until the earlier of 30 days after purchase of the second tranche or, if the second tranche is not funded, then 60 days after the closing date of the first tranche. The company will pay $6,000 as legal fees in its first and second tranche. The company issued the note pursuant to exemption provided under Regulation D. On the same day, the company has received its first tranche of $250,000.
